A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds Ozempic, Wegovy, Mounjaro or Zepbound, may help users overcome alcoholism and opioid addiction.

New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people with substance use disorders. These medications, often prescribed for diabetes and weight issues,

They’re tapping into the potential of Ozempic. Researchers from Loyola University Chicago are adding to the growing evidence suggesting that medications like Ozempic can treat substance abuse. Ozempic — which mimics the body’s naturally occurring GLP-1 hormone to make people feel full and eat less — treats diabetes and can spur weight loss.

A new study published today in Addiction suggests that Ozempic and similar medications may be able to help with treatment for opioid and alcohol use disorders.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive function by reducing inflammation.

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.